Category: Kratom

The Iowa City Council has initiated a controversial move to prohibit the sale of kratom, an herbal substance known for its opioid-like effects. In a tense meeting marked by divided opinions, the council voted to advance the ban, which would outlaw the sale and advertising of kratom while still permitting personal possession and use.

The decision came alongside a vote to advance new zoning regulations for tobacco retailers, aimed at limiting their proximity to schools and the University of Iowa. Both measures require two more rounds of approval before implementation.

Adding to the controversy, council members uncovered hundreds of fraudulent emails opposing the ban, sent under the names of real Iowa City residents who denied authoring them. This discovery raised concerns about the integrity of the public feedback process.

Supporters of the ban cited public health concerns, while opponents questioned the council’s role in regulating such substances. The debate reflects the ongoing national controversy surrounding kratom’s safety and efficacy.

The Czech Republic is set to implement new restrictions on the sale of psychomodulatory substances, including kratom and hexahydrocannabinol (HHC). On October 9, the Czech Senate passed an amendment to the Act on Addictive Substances, aiming to protect minors while avoiding outright prohibition.

If signed into law, these substances will only be available to adults in specialized stores starting December. The legislation also introduces online age verification requirements and bans sales through vending machines or as products resembling toys or sweets.

Senator Roman Kraus emphasized the importance of this regulation, noting that an estimated 200-300 tons of kratom are sold annually in the Czech Republic. The move comes in response to recent incidents involving minors and seeks to balance public health concerns with avoiding criminalization of users and sellers.

Florida lawmakers are considering new regulations for kratom, an herbal substance gaining traction for its purported pain relief and mood-enhancing properties. The debate centers on balancing consumer safety with access to the product, which is currently unregulated in the state.

State Representative Alex Andrade is spearheading efforts to implement the Kratom Consumer Protection Act, which would establish age restrictions and quality control measures for kratom products. The proposed legislation aims to ensure product purity and prevent adulteration with harmful substances.

While some tout kratom’s benefits, concerns persist about its potential for abuse and addiction. The Florida Legislature’s consideration of kratom regulation reflects a growing national conversation about the substance’s legal status and safety.

As discussions continue, stakeholders from various sectors are weighing in on the potential impacts of new regulations on consumers, businesses, and public health.

In a significant move for kratom consumers and the industry, Maryland Governor Wes Moore has signed the Kratom Consumer Protection Act into law. This landmark legislation, which took effect on September 19, 2024, establishes a comprehensive regulatory framework for kratom products in the state. The new law implements strict age restrictions, mandating that kratom can only be sold to individuals 21 and older. It also sets rigorous labeling requirements and quality control standards to ensure product safety and transparency. Maryland Matters reports that the act aims to protect consumers while allowing responsible access to kratom. This move positions Maryland as a leader in kratom regulation, potentially setting a precedent for other states considering similar legislation. The kratom industry and advocacy groups have largely welcomed the new law, viewing it as a balanced approach to regulation.

In a groundbreaking development, the U.S. Food and Drug Administration has conducted its first preliminary study on kratom, a botanical compound that has been the subject of much debate. The study’s findings suggest that kratom leaves, when consumed in capsule form, appear to be safe even at high doses.

This research marks a significant step in understanding the compound, which has been used for centuries in Southeast Asia. The FDA’s investigation aims to address the lack of scientific data surrounding kratom, which they had previously identified as a potential public health threat.

While the results are encouraging for capsule users, questions remain about the safety of kratom in other forms, particularly drinks and concentrates more commonly consumed in the U.S. These products typically contain higher levels of the compound and may pose different risks.

This study could have far-reaching implications for the regulation and perception of kratom in the United States.

The Indonesian government has taken a significant step in regulating its kratom trade by implementing two new ministerial regulations. According to a report from ANTARA News, these regulations aim to enhance the value and marketability of Indonesian kratom exports while ensuring product safety and preventing misuse.

Director General of Foreign Trade Isy Karim stated that kratom exports must now meet specific standards, including being free from microbiological contamination, heavy metals, and adulteration. The regulations outline prohibited types and sizes of kratom products for export, as well as requirements for exporters.

Importantly, these new rules apply only to exports and do not affect domestic use of kratom, a tropical tree native to Southeast Asia traditionally used as a stimulant and pain reliever. This move demonstrates Indonesia’s commitment to maintaining its position in the global kratom market while addressing safety concerns.

The kratom industry is making a concerted effort to establish a clear regulatory framework as the market continues to expand. Industry leaders are advocating for standardized quality control measures and consistent labeling requirements to ensure consumer safety and product reliability.

With the global kratom market projected to reach billions by 2028, stakeholders argue that proper regulation is crucial for sustainable growth. The American Kratom Association (AKA) is at the forefront of this initiative, working closely with legislators to develop comprehensive guidelines.

Proponents believe that a well-defined regulatory structure will not only protect consumers but also legitimize the industry in the eyes of skeptics. However, challenges remain, including varying state-level regulations and ongoing debates about kratom’s classification.

As discussions progress, the industry remains optimistic that a balanced approach to regulation will foster innovation while maintaining product integrity and consumer trust.

A New Jersey assemblyman is spearheading efforts to ban kratom, a controversial herbal supplement, following the death of a local resident. Assemblyman Sean Kean’s proposed legislation, dubbed “CJ’s Law,” aims to criminalize the manufacturing, distribution, and possession of kratom in the state.

The bill, named after Christopher James Holowach who died after mixing kratom with prescribed Adderall, could result in penalties of up to 10 years in prison and $150,000 in fines. Kean argues that despite kratom’s natural origins, it poses significant health risks, especially when combined with other substances.

If passed, New Jersey would join six other states in prohibiting kratom. The move comes amid growing concerns about the supplement’s safety, despite its reported use in treating various conditions. For more details on this developing story, visit the full article on WRNJ Radio.

The American Kratom Association (AKA) has formally requested FDA Commissioner Robert Califf to organize a public stakeholder meeting on kratom regulatory policies. In a letter dated September 4, 2024, the AKA highlighted inconsistencies in the FDA’s stance on kratom, noting that the agency has yet to definitively determine if kratom poses a danger to public health.

The AKA argues that the FDA has relied on questionable evidence to justify restricting access to kratom products. They hope this meeting will allow for a comprehensive evaluation of current science, consumer experiences, and expert opinions to shape a more informed regulatory approach.

Mac Haddow, Senior Fellow on Public Policy for the AKA, emphasized the importance of this two-way engagement in developing the best regulatory policy for kratom. The full details of the AKA’s request can be found on WRAL’s website.

A local kratom shop owner in Billings, Montana is speaking out against a proposed ban on the herbal supplement. The city council is considering prohibiting the sale of kratom, citing concerns about its safety and potential for abuse.

However, Dustin Olson, owner of Kratom Kave, argues that banning the product would be a mistake. He emphasizes that kratom has helped many people manage pain and anxiety, serving as an alternative to prescription medications.

Olson suggests that regulation, rather than outright prohibition, would be a more effective approach. He proposes implementing age restrictions and quality control measures to ensure product safety.

The debate highlights the ongoing controversy surrounding kratom, with supporters touting its benefits while critics raise health concerns. As the city council deliberates, the outcome could have significant implications for kratom users and businesses in Billings.

The legal status of kratom, an herbal supplement with both stimulant and sedative effects, is a complex and evolving issue across the United States. According to a recent analysis, the regulatory environment for kratom varies significantly from state to state. While some states have embraced kratom, allowing its sale and use, others have imposed strict bans due to safety concerns and potential for abuse.

The article highlights how this patchwork of regulations creates challenges for consumers and businesses, who must navigate differing laws depending on their location. These legal discrepancies are often influenced by local lobbying efforts and public health concerns. As the debate over kratom continues, its legal status remains a contentious topic, with significant implications for public health and commerce. For a detailed breakdown of kratom’s legal status across different jurisdictions, see the full article on Lawsuit Legal.

The American Kratom Association (AKA) is challenging the Food and Drug Administration’s (FDA) recent warning against OPMS Black Liquid Kratom. The FDA’s advisory, issued on July 26, claims the product is linked to severe health issues, including death. However, the AKA contends that these assertions are based on unverified evidence and are reminiscent of previously debunked claims. Mac Haddow, a Senior Fellow at the AKA, criticized the FDA for recycling old allegations, referencing a 2009 incident in Sweden where deaths were wrongly attributed to kratom. The AKA is demanding that FDA Commissioner Robert Califf retract the warning until the claims are independently confirmed. This pushback highlights ongoing tensions between the kratom industry and regulatory bodies. For more information, read the full article on Food Safety News.

On July 15, several new health laws took effect in Kentucky, addressing a range of issues from maternal health to allergy medication access. Among these is House Bill 293, aimed at regulating kratom, an herbal supplement often sold online and in convenience stores. Sponsored by Rep. Kim Moser, the bill prohibits sales to individuals under 21 and sets guidelines for manufacturing and labeling.

However, the implementation of this law is uncertain due to funding shortages. Governor Andy Beshear highlighted this issue in an April letter to legislators, listing HB 293 among 22 laws facing financial hurdles.

For a detailed overview of these new laws and their implications, read the full article on NKyTribune.